Prev Med 42:60–65PubMedCrossRef Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper

M, Calonge N, Dotson WD, Douglas MP, Berg AO (2009) The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP working group. Genet Med 11:3–14PubMedCrossRef Toiviainen H, Jallinoja P, Aro AR, Hemminki E (2003) Medical and lay attitudes towards genetic screening and testing in Finland. Eur J Hum Genet 11:565–572PubMedCrossRef Ward VM, Bertrand JT, Brown LF (1991) The comparability of focus group and survey results. Eval Rev 42:702–737 Ward V, House A, Hamer S (2009) Developing a framework for transferring knowledge into action: a thematic analysis of the literature. J Health Serv Res Policy 14:156–164PubMedCrossRef Wutich A, Lant T, White DD, Larson KL, Gartin M (2010) Comparing focus group and individual responses on sensitive topics: a study of RGFP966 mw water decision makers in a desert city. Field Methods 22:88–110CrossRef”
“Introduction Genetic factors are of paramount Entospletinib datasheet importance for normal development and health. Abnormal genes and abnormal expression of genes may therefore lead to birth defects and diseases. Although the same applies for many exogenous factors, I focus here on the genetic ones. A further focus will be on genetic factors whose knowledge is of relevance for

reproductive choice. Psychological and ethical issues will be discussed in the papers by Riedijk et al. (this issue) and De Wert et al. (this issue); future methods of genetic risk assessment will be discussed in the paper by Ropers (this issue). Relevance of knowledge of genetic risk Two main reasons for identifying

genetic risk in the preconception period are that preconception knowledge of genetic risk may influence care and also may allow informed reproductive choice. Knowledge of genetic risk may influence Rho preconception care, prenatal care, mode of delivery and postnatal care. Previous birth of a child with a neural tube defect—a multifactorial genetic condition—indicates a higher dose of folic acid supplementation preconceptionally and in the first months of pregnancy, than for a woman without neural tube defects in her family (Grosse and Collins 2007). Preeclampsia in a sister of a pregnant woman leads to a higher level of alertness for click here related symptoms during prenatal care. Dexamethasone treatment in an unborn sib of a child with congenital adrenal hyperplasia has to start as soon as the pregnancy is confirmed, well before invasive prenatal diagnosis of the foetus is possible (Nimkarn and New 2010). Preconception knowledge of genetic risk also allows informed reproductive choice. Consider a couple in which both partners are carriers of an autosomal recessive disease like cystic fibrosis. What options do they have? If they conceive normally, the child will have a 25% risk of being affected by this disease.